6-K

FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

For the month of:   May, 2014

Commission File Number:                 01-15016                      

NORDION INC.

(Translation of registrant's name into English)

447 March Road

Ottawa, Ontario Canada  K2K 1X8

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F......... Form 40-F....X.....

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	NORDION INC.
Date:    May 23, 2014	By:	/s/ Grant Gardiner
		Grant Gardiner
		Title:  Senior Vice President, General Counsel & Corporate Secretary

Documents Included as Part of this report:

No.	Document
1.	NORDION INC.  - Nordion Provides Information on Annual and Special Shareholder Meeting

EX-99.1

For Immediate Release

Nordion Provides Information on Annual and Special Shareholder Meeting

Shareholder proxy voting deadline today

Teleconference for Meeting requires pre-registration

OTTAWA, CANADA – May 23, 2014 – Nordion Inc. (TSX:NDN) (NYSE:NDZ) is issuing a reminder to shareholders that today is the proxy voting deadline and is providing additional information with regards to the logistics for the Company’s Annual and Special Meeting of Shareholders (the “Meeting”) being held on May 27, 2014.  As referenced in the Information Circular, the Meeting will be held at 2:00 p.m. (Eastern time) at the Brookstreet Hotel, 525 Legget Drive, Ottawa, ON, Canada.

Your vote is important regardless of the number of Common Shares you hold.  Your votes must be received by Nordion’s transfer agent, CST Trust Company, no later than 5:00 p.m. (Eastern Time) today, May 23, 2014. You are entitled to receive notice of, and vote at, the Meeting or any postponement(s) or adjournment(s) thereof if you were a Shareholder on April 24, 2014.

For those Shareholders that cannot attend the Meeting in person, Nordion has made arrangements to provide a live teleconference of the Meeting.  However, Shareholders will not be permitted to vote or otherwise participate in the Meeting through the teleconference facility.

To attend via Teleconference, you must register in advance at:

https://selfreg-inscriptionauto.confsolutions.ca/webportal/reg.html?Acc=6236061574&Conf=145997

Passcode and PIN will be provided upon registration.

Canadian Shareholders who require assistance in voting their proxies may direct their inquiries to Nordion’s proxy solicitation agent for Canada, CST Phoenix Advisors, by toll-free telephone in North America at 1-800-332-4904 or at 1-201-806-2222 outside of North America.

U.S. Shareholders who require assistance in voting their proxies may direct their inquiries to Nordion's proxy solicitation agent for the U.S., Innisfree M&A Incorporated, by toll-free telephone in North America at 1-888-750-5834, or collect at 1-212-750-5833.

About Nordion Inc. 

Nordion Inc. (TSX:NDN) (NYSE:NDZ) is a global health science company that provides market-leading products used for the prevention, diagnosis and treatment of disease. We are a leading provider of medical isotopes and sterilization technologies that benefit the lives of millions of people in more than 40 countries around the world. Our products are used daily by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories. Nordion has over 400 highly skilled employees in three locations. Find out more at www.nordion.com and follow us at twitter.com/NordionInc.

CONTACTS:

INVESTORS:

Ana Raman

(613) 595-4580

investor.relations@nordion.com

MEDIA:

Shelley Maclean

(613) 592-3400 x 2414

shelley.maclean@nordion.com

 SOURCE: Nordion